Product NDC: | 54868-1208 |
Proprietary Name: | Depakote |
Non Proprietary Name: | divalproex sodium |
Active Ingredient(s): | 250 mg/1 & nbsp; divalproex sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54868-1208 |
Labeler Name: | Physicians Total Care, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018723 |
Marketing Category: | NDA |
Start Marketing Date: | 19960213 |
Package NDC: | 54868-1208-6 |
Package Description: | 30 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (54868-1208-6) |
NDC Code | 54868-1208-6 |
Proprietary Name | Depakote |
Package Description | 30 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (54868-1208-6) |
Product NDC | 54868-1208 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | divalproex sodium |
Dosage Form Name | TABLET, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 19960213 |
Marketing Category Name | NDA |
Labeler Name | Physicians Total Care, Inc. |
Substance Name | DIVALPROEX SODIUM |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |